In the wake of gutting USAID, Donald Trump’s administration is rolling out a new “America First” global health strategy that it sees as the future of foreign assistance: granting money in return for data.
In memorandums of understanding (MOUs) signed with more than 30 nations since December, worth $20.6bn, governments have accepted five years of funding — often much reduced from previous levels — in return for a pledge to provide up to 25 years of patient data and, in some cases, pathogenic specimens, along with a commitment to co-invest.
Recipient countries have promised to stump up $7.8bn, about a third of the total, and the US can withdraw funding if it determines nations are not meeting their co-investment pledges.